![]() ![]() T1 - Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal CancerÄisclosures: All panelists were required to declare all conflicts of interest for the previous 36 months before initiating work on this document. receives research grants from Merck and Nestle and personal fees from Elekta.", receives consulting fees and an honorarium from Varian and Carl Zeiss. receives consulting fees and an honorarium from Sirtex Medical. receives consulting fees and an honorarium from AstraZeneca, Varian, and ViewRay and a research grant from AstraZeneca. serves on the Advisory Board for RenovoRx. receives consulting fees and an honorarium for the Data Safety Monitoring Board of Eisai Medical Research. Disclosures potentially relevant to the content of this guideline are provided. ![]() The American Radium Society Appropriate Use Criteria Steering Committee reviewed these disclosures with the chair of this document and approved participation of the panelists before starting development of this work. These complete disclosure forms are retained by the American Radium Society in perpetuity. Disclosures: All panelists were required to declare all conflicts of interest for the previous 36 months before initiating work on this document. Koong, MD Miguel Rodriguez-Bigas, MD Charles R. Herman, MD, MSc, MSHCM Andre Konski, MD Andrea Taylor Theodore S. Funding Information: The American Radium Society Appropriate Use Criteria Steering Committee Sue Yom, MD, PhD Joseph M. receives research grants from Merck and Nestle and personal fees from Elekta. Note = "Funding Information: Disclosures: All panelists were required to declare all conflicts of interest for the previous 36 months before initiating work on this document. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |